📰 Athersys Inc News
Page 2 - Athersys Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Athersys Inc. Real-time updates on events, politics, business and more.
February 10, 2024
Research analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Thursday. Athersys has a twelve month low of $0.01 and a twelve month high […]
February 7, 2024
This exploratory analysis of the SELECT2 trial assesses the relationship between imaging estimates of irreversibly injured brain (core) and at-risk regions (mis
January 31, 2024
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is estimated to increase by USD 2.38 billion from 2023 to 2027, with a CAGR of...
January 27, 2024
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Tuesday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The […]
January 27, 2024
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.02 on Tuesday. The company’s fifty day moving average is $0.02 and its two-hundred day moving […]
January 18, 2024
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance NASDAQ:ATHX opened at $0.03 on Monday. The firm’s 50-day moving average price is $0.02 and its 200-day moving average price […]
January 11, 2024
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Trading Down 51.1 % ATHX stock opened at $0.01 on Friday. The firm has a market cap of $407,352.00, a P/E ratio of 0.00 and […]
January 11, 2024
StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Athersys stock opened at $0.01 on Friday. The stock has a fifty day moving average of $0.02 and a 200-day moving […]
January 10, 2024
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance Shares of ATHX stock opened at $0.01 on Friday. The firm has a market capitalization of $833,220.00, a price-to-earnings ratio of -0.01 […]
January 1, 2024
Analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX opened at $0.00 on Thursday. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99. […]